Pharma and Medical Device Investigations

In recent years, the U.S. Department of Justice, the Food and Drug Administration, and the Health and Human Services Department have steadily increased the number of investigations and prosecutions brought against pharmaceutical and medical device companies for alleged “off-label” or misbranding violations of the Food Drug and Cosmetic Act and the False Claims Act.

Our attorneys have represented numerous employees and executives from both the pharmaceutical and medical device industries in these investigations. And we have achieved extraordinary success in helping our clients navigate these investigations and avoid any criminal or civil prosecution.

Comments are closed.